Olivier de Mouzon : Citation Profile

Are you Olivier de Mouzon?

Toulouse School of Economics (TSE)

3

H index

1

i10 index

90

Citations

RESEARCH PRODUCTION:

2

Articles

11

Papers

RESEARCH ACTIVITY:

   9 years (2009 - 2018). See details.
   Cites by year: 10
   Journals where Olivier de Mouzon has often published
   Relations with other researchers
   Recent citing documents: 28.    Total self citations: 1 (1.1 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pde716
   Updated: 2023-01-08    RAS profile: 2017-12-05    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Lepelley, Dominique (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Olivier de Mouzon.

Is cited by:

Réquillart, Vincent (5)

Dubois, Pierre (5)

Dranove, David (4)

Clemens, Jeffrey (4)

Gaulé, Patrick (3)

Gamba, Simona (3)

Bonnet, Céline (3)

Williams, Heidi (3)

Sæthre, Morten (3)

Agarwal, Ruchir (3)

Hollis, Aidan (2)

Cites to:

Lepelley, Dominique (13)

Merlin, Vincent (8)

Jensen, Helen (4)

Lin, Biing-Hwan (4)

pan, suwen (3)

Guthrie, Joanne (3)

Ver Ploeg, Michele (3)

Bresnahan, Timothy (2)

Frazao, Elizabeth (2)

Berry, Steven (2)

Meyerhoefer, Chad (2)

Main data

Where Olivier de Mouzon has published?

Working Papers Series with more than one paper published# docs
TSE Working Papers / Toulouse School of Economics (TSE)5
IDEI Working Papers / Institut d'Économie Industrielle (IDEI), Toulouse3

Recent works citing Olivier de Mouzon (2022 and 2021)

YearTitle of citing document
2021Product recalls, market size and innovation in the pharmaceutical industry. (2021). Morescalchi, Andrea ; Riccaboni, Massimo ; Nutarelli, Federico. In: Papers. RePEc:arx:papers:2111.15389.

Full description at Econpapers || Download paper

2022Welfare ordering of voting weight allocations. (2022). Kikuchi, Kazuya. In: Papers. RePEc:arx:papers:2208.05316.

Full description at Econpapers || Download paper

2021Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly. (2021). Gamba, Simona ; Florio, Massimo. In: Annals of Public and Cooperative Economics. RePEc:bla:annpce:v:92:y:2021:i:3:p:387-409.

Full description at Econpapers || Download paper

2021Medicare and the Rise of American Medical Patenting: The Economics of User-Driven Innovation. (2021). Clemens, Jeffrey ; Olsen, Morten. In: CESifo Working Paper Series. RePEc:ces:ceswps:_9008.

Full description at Econpapers || Download paper

2021Medical Innovations and Ageing: A Health Economics Perspective. (2021). Grossmann, Volker. In: CESifo Working Paper Series. RePEc:ces:ceswps:_9387.

Full description at Econpapers || Download paper

2021Public health insurance and pharmaceutical innovation: Evidence from China. (2021). Nie, Huihua ; Zhang, Xuan. In: Journal of Development Economics. RePEc:eee:deveco:v:148:y:2021:i:c:s030438782030153x.

Full description at Econpapers || Download paper

2021Welfare effects of public procurement of medicines: Evidence from Ecuador. (2021). Mohapatra, Debi Prasad ; Callejas, Jeronimo. In: International Journal of Industrial Organization. RePEc:eee:indorg:v:75:y:2021:i:c:s016771872030120x.

Full description at Econpapers || Download paper

2021R&D and market size: Who benefits from orphan drug legislation?. (2021). Pertile, Paolo ; Gamba, Simona ; Magazzini, Laura. In: Journal of Health Economics. RePEc:eee:jhecon:v:80:y:2021:i:c:s0167629621001077.

Full description at Econpapers || Download paper

2022The economics of medical procedure innovation. (2022). Dranove, David ; Wu, Bingxiao ; Heard, Christopher ; Garthwaite, Craig. In: Journal of Health Economics. RePEc:eee:jhecon:v:81:y:2022:i:c:s016762962100134x.

Full description at Econpapers || Download paper

2022What drives innovation? Lessons from COVID-19 R&D. (2022). Gaulé, Patrick ; Gaule, Patrick ; Agarwal, Ruchir. In: Journal of Health Economics. RePEc:eee:jhecon:v:82:y:2022:i:c:s016762962200011x.

Full description at Econpapers || Download paper

2022Global drug diffusion and innovation with the medicines patent pool. (2022). Wang, Lucy Xiaolu. In: Journal of Health Economics. RePEc:eee:jhecon:v:85:y:2022:i:c:s0167629622000868.

Full description at Econpapers || Download paper

2021Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling. (2021). Chatterjee, Chirantan ; Yan, Xin ; Higgins, Matthew J. In: Research Policy. RePEc:eee:respol:v:50:y:2021:i:1:s0048733320302018.

Full description at Econpapers || Download paper

2021In search of an appropriate mix of taxes and subsidies on nutrients and food: A modelling study of the effectiveness on health-related consumption and mortality. (2021). Nordström, Jonas ; Gerdtham, Ulf-G. ; Nordstrom, Jonas ; Saha, Sanjib ; Gerdtham, Ulf-G., ; Gerdtham , Ulf-G., ; Thunstrom, Linda ; Scarborough, Peter. In: Social Science & Medicine. RePEc:eee:socmed:v:287:y:2021:i:c:s0277953621007206.

Full description at Econpapers || Download paper

2021Information asymmetry, risk aversion and R&D subsidies: Effect-size heterogeneity and policy conundrums. (2021). Ugur, Mehmet ; Trushin, Eshref. In: Greenwich Papers in Political Economy. RePEc:gpe:wpaper:32224.

Full description at Econpapers || Download paper

2021What Drives Innovation? Lessons from COVID-19 R&D. (2021). Gaulé, Patrick ; Gaule, Patrick ; Agarwal, Ruchir. In: IMF Working Papers. RePEc:imf:imfwpa:2021/048.

Full description at Econpapers || Download paper

2021Rushed Innovation: Evidence from Drug Licensing. (2021). Hermosilla, Manuel. In: Management Science. RePEc:inm:ormnsc:v:67:y:2021:i:1:p:257-278.

Full description at Econpapers || Download paper

2021What Drives Innovation? Lessons from COVID-19 R&D. (2021). Agarwal, Ruchir ; Gaule, Patrick. In: IZA Discussion Papers. RePEc:iza:izadps:dp14079.

Full description at Econpapers || Download paper

2021The Economics of Medical Procedure Innovation. (2021). Dranove, David ; Wu, Bingxiao ; Heard, Christopher ; Garthwaite, Craig. In: NBER Working Papers. RePEc:nbr:nberwo:29438.

Full description at Econpapers || Download paper

2022NIH Grant Expansion, Ancestral Diversity and Scientific Discovery in Genomics Research. (2022). Chou, Shin-Yi ; Fu, Wei ; Wang, Li-San. In: NBER Working Papers. RePEc:nbr:nberwo:30155.

Full description at Econpapers || Download paper

2021Revisiting the Relationship Between Price Regulation and Pharmaceutical R&D Investment. (2021). Shaikh, Mujaheed ; Kourouklis, Dimitrios ; Giudice, Pietro. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:2:d:10.1007_s40258-020-00601-9.

Full description at Econpapers || Download paper

2021Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model. (2021). Dosi, Giovanni ; Russo, Emanuele ; Roventini, Andrea ; Palagi, Elisa. In: LEM Papers Series. RePEc:ssa:lemwps:2021/37.

Full description at Econpapers || Download paper

2022Bargaining and International Reference Pricing in the Pharmaceutical Industry. (2022). Vasserman, Shoshana ; Gandhi, Ashvin ; Dubois, Pierre. In: TSE Working Papers. RePEc:tse:wpaper:126993.

Full description at Econpapers || Download paper

2022The Economics of Transferable Patent Extensions. (2022). Dubois, Pierre ; Moisson, Paul-Henri ; Tirole, Jean. In: TSE Working Papers. RePEc:tse:wpaper:127464.

Full description at Econpapers || Download paper

2022Mergers and Advertising in the Pharmaceutical Industry. (2022). Dubois, Pierre ; Majewska, Gosia. In: TSE Working Papers. RePEc:tse:wpaper:127469.

Full description at Econpapers || Download paper

2021Marketing communication tools and their influence on marketing innovation: Evidence from Slovakian SMEs. (2021). Vaclav, Netek ; Krzysztof, Gajdka ; Michal, Ervinka ; Mehmet, Civelek. In: Management & Marketing. RePEc:vrs:manmar:v:16:y:2021:i:3:p:210-227:n:5.

Full description at Econpapers || Download paper

2021Regulatory review time and pharmaceutical research and development. (2021). Bailey, James ; Chorniy, Anna ; Maloney, Michael ; Civan, Abdulkadir . In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:1:p:113-128.

Full description at Econpapers || Download paper

2021The economic theory of cost?effectiveness thresholds in health: Domestic and international implications. (2021). Hollis, Aidan ; Moradpour, Javad. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:5:p:1139-1151.

Full description at Econpapers || Download paper

2021INNOVATION AND DIFFUSION OF MEDICAL TREATMENT. (2021). Papageorge, Nicholas ; Hamilton, Barton H ; Miller, Robert A ; Hincapie, Andres. In: International Economic Review. RePEc:wly:iecrev:v:62:y:2021:i:3:p:953-1009.

Full description at Econpapers || Download paper

Works by Olivier de Mouzon:

YearTitleTypeCited
2010ARE FRUIT AND VEGETABLE STAMP POLICIES COST-EFFECTIVE? In: 115th Joint EAAE/AAEA Seminar, September 15-17, 2010, Freising-Weihenstephan, Germany.
[Full Text][Citation analysis]		paper2
2010Are Fruit and Vegetable Stamp Policies Cost Effective?.(2010) In: IDEI Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 2		paper
2011An Analysis of Taste Variety within Households on Soft Drinks In: 2011 International Congress, August 30-September 2, 2011, Zurich, Switzerland.
[Full Text][Citation analysis]		paper0
2015Market size and pharmaceutical innovation In: RAND Journal of Economics.
[Full Text][Citation analysis]		article73
2011Market Size and Pharmaceutical Innovation.(2011) In: CEPR Discussion Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 73		paper
2014Market Size and Pharmaceutical Innovation.(2014) In: IDEI Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 73		paper
2014Market Size and Pharmaceutical Innovation.(2014) In: TSE Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 73		paper
2009Increasing Fruits and Vegetables Consumption: A Cost-Efficiency Analysis of Public Policies In: IDEI Working Papers.
[Full Text][Citation analysis]		paper7
2009Increasing Fruits and Vegetables Consumption: A Cost-Efficiency Analysis of Public Policies.(2009) In: TSE Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 7		paper
2012Are fruit and vegetable voucher policies cost-effective? In: European Review of Agricultural Economics.
[Full Text][Citation analysis]		article1
2014Analysis of Multiple Discrete-Continuous Choices: Empirical Evidence of Biased Price Elasticities under Standard Discrete Choice models on the Soft Drink Market In: TSE Working Papers.
[Full Text][Citation analysis]		paper0
2018The Theoretical Shapley-Shubik Probability of an Election Inversion in a Toy Symmetric Version of the U.S. Presidential Electoral System In: TSE Working Papers.
[Full Text][Citation analysis]		paper5
2018Exploring the Effects on the Electoral College of National and Regional Popular Vote Interstate Compact: An Electoral Engineering Perspective In: TSE Working Papers.
[Full Text][Citation analysis]		paper2

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated January, 6 2023. Contact: CitEc Team